Weight Loss and Weight Regain in Usual Clinical Practice: Results From the TARGET-NASH Observational Cohort.

Authors :: Malespin MH
Barritt AS 4th
Watkins SE
Schoen C
Tincopa MA
Corbin KD
Mospan AR
Munoz B
Trinh HN
Weiss LM
Reddy KR
Loomba R
Kemmer N
Lok AS
Source :: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2022 Oct; Vol. 20 (10), pp. 2393-2395.e4. Date of Electronic Publication: 2021 Jan 21.
Publication Year :: 2022
Abstract: First-line treatment for nonalcoholic fatty liver disease (NAFLD) focuses on weight loss through lifestyle modifications. <superscript>1,2</superscript> Weight loss ≥5% results in reduction of steatosis and weight loss ≥10% has been associated with improvement in hepatic inflammation and fibrosis. <superscript>3</superscript> The incidence and sustainability of weight loss among patients with NAFLD were estimated and associating factors identified.<br /> (Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.)

Subjects :: Cohort Studies
Humans
Life Style
Liver
Weight Gain
Weight Loss
Non-alcoholic Fatty Liver Disease therapy

Language :: English
ISSN :: 1542-7714
Volume :: 20
Issue :: 10
Database :: MEDLINE
Journal :: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Publication Type :: Academic Journal
Accession number :: 33486083
Full Text :: https://doi.org/10.1016/j.cgh.2021.01.023

Full Text Access

Tools